CINRYZE

STN: 125267
Proper Name: C1 Esterase Inhibitor (Human)
Tradename: CINRYZE
Manufacturer: ViroPharma Biologics LLC
 

Indication

• For routine prophylaxis against angioedema attacks in patients with Hereditary Angioedema (HAE).

Product Information

• Package Insert - CINRYZE

Supporting Documents

• April 1, 2022 Approval Letter - CINRYZE
• June 20, 2018 Approval Letter - CINRYZE
• June 20, 2018 Summary Basis for Regulatory Action - CINRYZE
• Approval History, Letters, Reviews and Related Documents - CINRYZE
• Supporting Documents older than three years - CINRYZE

Related Information

• C1 Esterase Inhibitor